(c) 2025 PillSync.com

abiraterone 500 mg

1 INDICATIONS AND USAGE Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablets are a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). ( 1 ) metastatic high-risk castration-sensitive prostate cancer (CSPC). ( 1 )

florida pharmaceutical products, llc


4 weeks ago OVAL PURPLE A 500 abiraterone 500 mg

OVAL PURPLE A 500

16 HOW SUPPLIED/STORAGE AND HANDLING

ABIRATERONE ACETATE Tablets, 500 mg are purple colored, oval shaped, biconvex bevel edged film-coated tablets, debossed with “A” one side and “500” on the other side. Bottles of 60 tablets with child-resistant closure NDC 71921-177-06 Storage and Handling Store at 20°C to 25°C (68°F to 77°F); excursions permitted in the range from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature] . Keep out of reach of children. Based on its mechanism of action,

ABIRATERONE ACETATE tablets may harm a developing fetus. Women who are pregnant or women who may be pregnant should not handle

ABIRATERONE ACETATE tablets if broken, crushed, or damaged without protection, e.g., gloves [see Use in Specific Populations (8.1) ] .


More pills like OVAL A 500












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site